Home

PAR-19-277 - Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 4

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity NOT-CA-22-001 NCI , NHLBI Nov 4, 2021 Nov 6, 2024 R01, R03, R21, P01

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Early-life Factors and Cancer Development Later in Life NOT-CA-21-074 NCI May 5, 2021 Mar 8, 2024 R01, R21, R03
Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes NOT-CA-21-031 NCI NIA Jan 27, 2021 Jan 8, 2024 R21, R03, R01, U01, P01, K99/R00, K08, R43/R44, R41/R42, R13, R21/R33, K01, K23
Notice of Special Interest (NOSI): Geospatial Approaches in Cancer Control and Population Sciences NOT-CA-20-004 NCI Oct 22, 2019 Jan 8, 2022 R01, R21


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health